1. Holiday Fundraiser

    UPDATED INFORMATION! Merry Christmas! Help us meet our Christmas Fundraising Goal! FRN is in it for the long haul, despite constant attacks from the Atlantic Council and NATO. We're in the game because of the support of readers like you. God Bless! IF OUR INTERFACE ISN'T WORKING FOR YOU, OR IF YOU WANT TO USE YOUR PAYPAL DIRECTLY TO FORT RUSS - HERE'S OUR PAYPAL ADDRESS! -- [email protected]
    $1,278.87 donated of $3,000.00 goal

    Read More

Non-addictive painkiller more powerful than morphine created by Russian scientists

0 41

November 18, 2017 – Fort Russ News – Paul Antonopoulos

PYATIGORSK, Russia – Department head of the Volgograd State Medical University and RAS Member, Alexander Spasov, told TASS on Friday in Pyatigorsk have announced that clinical tests have begun on a new painkiller that is not addictive but outperforms morphine.

- Advertisement -

“Together with our colleagues from the South Federal University, we created a drug which still has no specific name but is only referred to as RU-1205,” Spasov announced at the 3rd International Research and Practice Conference on Experimental and Clinical Pharmacology. 

“Based on its effect, it outperforms such well-known painkillers as morphine and promedol and does not cause addictive side effects,” he explained. 

“Now, a full round of preclinical studies has been completed, and we are negotiating with two plants that are supposed to bankroll clinical research and initiate industrial production. At present, there isn’t a similar drug like this anywhere in the world,” he announced.

“A pain-killing drug, which outperforms morphine, and does not cause mental or physical addiction, is a huge breakthrough. This medication may set off a small revolution in pharmacology. It will save patients from subsequent addiction, it takes away the possibility of a drug habit setting in, which occurs when using morphine products over the long term,” Spasov pointed out.

Subscribe to our newsletter
Sign up here to get the latest news, updates and special offers delivered directly to your inbox.

Get real time updates directly on you device, subscribe now.

Comments